FDA releases weekly update on user fee letters and new HHS regulatory agenda
read at raps ↗RegulatoryNeutral
The FDA's latest weekly briefing highlighted the release of user fee commitment letters, which outline the agency's financial planning for upcoming fiscal periods.
It also introduced a new regulatory agenda from the Department of Health and Human Services, signaling upcoming policy priorities for drug and device oversight.
The update serves as a concise source for professionals tracking regulatory changes, linking to relevant documents and commentary from industry observers.
source
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “This Week at FDA: User fee commitment letters, new HHS regulatory agenda, and more”
read at raps ↗
comments(0)
5-min edit window · permanent after that